Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3583791

Cc1cn(CC(=O)O)c(C)n1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
LMNA P02545 1/20 0.37
CYP19A1 P11511 1/20 0.36
RXFP1 Q9HBX9 1/20 0.35
PPARD Q03181 2/20 0.35
PPARA Q07869 2/20 0.35
AKR1A1 P14550 1/20 0.34
AKR1B1 P15121 1/20 0.34
NR3C1 P04150 1/20 0.34
NR3C2 P08235 1/20 0.34
ALPL P05186 2/20 0.33
PKM P14618 1/20 0.33
PLAA Q9Y263 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4453709 0.90 ALDH1A1 (0.46) KDM4EALDH1A1POLBMAPTLMNA
Trifluoroacetic Acid SCHEMBL16700571 0.87 ALDH1A1 (0.44) KDM4EALDH1A1LMNACYP19A1RXFP1
Trifluoroacetic Acid SCHEMBL3586206 0.84 KDM4E (0.37) KDM4EALDH1A1POLBMAPTLMNA
Trifluoroacetic Acid SCHEMBL3586713 0.83 CYP19A1 (0.51) KDM4EALDH1A1POLBMAPTLMNA
SCHEMBL15484840 0.79 KDM4E (0.44) KDM4EALDH1A1POLBMAPTLMNA
SCHEMBL13712183 0.74 HTT (0.40) LMNACYP19A1RXFP1ALPLPKM
SCHEMBL28711155 0.73 ALDH1A1 (0.43) KDM4EALDH1A1POLBMAPTLMNA
SCHEMBL13031253 0.73 ALDH1A1 (0.43) KDM4EALDH1A1POLBMAPTLMNA
SCHEMBL13031308 0.71 CYP19A1 (0.58) KDM4EALDH1A1POLBMAPTLMNA
SCHEMBL3588609 0.71 ALDH1A1 (0.42) KDM4EALDH1A1POLBMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286191-A1 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators MERCK SHARP & DOHME CORP. 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286191-A1 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators CXCR3, CXCR1, CXCR2 KDM4E 3447/4885ALDH1A1 971/4885POLB 4548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.